Figure S1.
This supplemental material reports the citations of all included studies in the literature review.
1: Abramson VG, Cooper Lloyd M, Ballinger T, Sanders ME, Du L, Lai D, Su Z, Mayer
I, Levy M, LaFrance DR, Vnencak-Jones CL, Shyr Y, Dahlman KB, Pao W, Arteaga CL.
Characterization of breast cancers with PI3K mutations in an academic practice
setting using SNaPshot profiling. Breast Cancer Res Treat. 2014
Jun;145(2):389-99. doi: 10.1007/s10549-014-2945-3. Epub 2014 Apr 11. PubMed PMID:
24722917; PubMed Central PMCID: PMC4046906.
2: Adams HR, Rose K, Augustine EF, Kwon JM, deBlieck EA, Marshall FJ, Vierhile A,
Mink JW, Nance MA. Experience, knowledge, and opinions about childhood genetic
testing in Batten disease. Mol Genet Metab. 2014 Feb;111(2):197-202. doi:
10.1016/j.ymgme.2013.10.017. Epub 2013 Nov 4. PubMed PMID: 24246680; PubMed
Central PMCID: PMC3919022.
3: Aiyar L, Shuman C, Hayeems R, Dupuis A, Pu S, Wodak S, Chitayat D, Velsher L,
Davies J. Risk estimates for complex disorders: comparing personal genome testing
and family history. Genet Med. 2014 Mar;16(3):231-7. doi: 10.1038/gim.2013.115.
Epub 2013 Sep 5. PubMed PMID: 24009002.
4: Akpinar A, Ersoy N. Attitudes of physicians and patients towards disclosure of
genetic information to spouse and first-degree relatives: a case study from
Turkey. BMC Med Ethics. 2014 May 16;15:39. doi: 10.1186/1472-6939-15-39. PubMed
PMID: 24885495; PubMed Central PMCID: PMC4029893.
5: Al-Farsi OA, Al-Farsi YM, Gupta I, Ouhtit A, Al-Farsi KS, Al-Adawi S. A study
on knowledge, attitude, and practice towards premarital carrier screening among
adults attending primary healthcare centers in a region in Oman. BMC Public
Health. 2014 Apr 17;14:380. doi: 10.1186/1471-2458-14-380. PubMed PMID: 24742222;
PubMed Central PMCID: PMC4004421.
6: Alderfer MA, Zelley K, Lindell RB, Novokmet A, Mai PL, Garber JE, Nathan D,
Scollon S, Chun NM, Patenaude AF, Ford JM, Plon SE, Schiffman JD, Diller LR,
Savage SA, Malkin D, Ford CA, Nichols KE. Parent decision-making around the
genetic testing of children for germline TP53 mutations. Cancer. 2015 Jan
15;121(2):286-93. doi: 10.1002/cncr.29027. Epub 2014 Sep 15. PubMed PMID:
25223899.
7: Alexander KM, Divine HS, Hanna CR, Gokun Y, Freeman PR. Implementation of
personalized medicine services in community pharmacies: perceptions of
independent community pharmacists. J Am Pharm Assoc (2003). 2014
Sep-Oct;54(5):510-7, 5 p following 517. doi: 10.1331/JAPhA.2014.13041. PubMed
PMID: 25148656.
8: Allyse M, Sayres LC, Goodspeed TA, Cho MK. Attitudes towards non-invasive
prenatal testing for aneuploidy among US adults of reproductive age. J Perinatol.
2014 Jun;34(6):429-34. doi: 10.1038/jp.2014.30. Epub 2014 Mar 6. PubMed PMID:
24603453; PubMed Central PMCID: PMC4399855.
9: Amiet C, Couchon E, Carr K, Carayol J, Cohen D. Are there cultural differences
in parental interest in early diagnosis and genetic risk assessment for autism
spectrum disorder? Front Pediatr. 2014 Apr 23;2:32. doi: 10.3389/fped.2014.00032.
eCollection 2014. PubMed PMID: 24795872; PubMed Central PMCID: PMC4006049.
10: Andersen MR, Thorpe J, Buist DS, Beatty JD, Watabayashi K, Hanson N, Resta R,
Chubak J, Urban N. Cancer Risk Awareness and Concern among Women with a Family
History of Breast or Ovarian Cancer. Behav Med. 2016;42(1):18-28. doi:
10.1080/08964289.2014.947234. Epub 2014 Nov 3. PubMed PMID: 25062114; PubMed
Central PMCID: PMC4469617.
11: Anderson AE, Flores KG, Boonyasiriwat W, Gammon A, Kohlmann W, Birmingham WC,
Schwartz MD, Samadder J, Boucher K, Kinney AY. Interest and informational
preferences regarding genomic testing for modest increases in colorectal cancer
risk. Public Health Genomics. 2014;17(1):48-60. doi: 10.1159/000356567. Epub 2014
Jan 14. PubMed PMID: 24435063; PubMed Central PMCID: PMC3992284.
12: Andrews V, Tonkin E, Lancastle D, Kirk M. Using the Diffusion of Innovations
theory to understand the uptake of genetics in nursing practice: identifying the
characteristics of genetic nurse adopters. J Adv Nurs. 2014 Apr;70(4):878-93.
doi: 10.1111/jan.12255. Epub 2013 Sep 15. PubMed PMID: 24102681.
13: André F, Bachelot T, Commo F, Campone M, Arnedos M, Dieras V, Lacroix-Triki
M, Lacroix L, Cohen P, Gentien D, Adélaide J, Dalenc F, Goncalves A, Levy C,
Ferrero JM, Bonneterre J, Lefeuvre C, Jimenez M, Filleron T, Bonnefoi H.
Comparative genomic hybridisation array and DNA sequencing to direct treatment of
metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER).
Lancet Oncol. 2014 Mar;15(3):267-74. doi: 10.1016/S1470-2045(13)70611-9. Epub
2014 Feb 7. PubMed PMID: 24508104.
14: Arnold AG, Otegbeye E, Fleischut MH, Glogowski EA, Siegel B, Boyar SR,
Salo-Mullen E, Amoroso K, Sheehan M, Berliner JL, Stadler ZK, Kauff ND, Offit K,
Robson ME, Zhang L. Assessment of individuals with BRCA1 and BRCA2 large
rearrangements in high-risk breast and ovarian cancer families. Breast Cancer Res
Treat. 2014 Jun;145(3):625-34. doi: 10.1007/s10549-014-2987-6. Epub 2014 May 14.
PubMed PMID: 24825132.
15: Ashida S, Schafer EJ. Family health information sharing among older adults:
reaching more family members. J Community Genet. 2015 Jan;6(1):17-27. doi:
10.1007/s12687-014-0197-x. Epub 2014 Jul 30. PubMed PMID: 25074679; PubMed
Central PMCID: PMC4286562.
16: Ayme A, Viassolo V, Rapiti E, Fioretta G, Schubert H, Bouchardy C, Chappuis
PO, Benhamou S. Determinants of genetic counseling uptake and its impact on
breast cancer outcome: a population-based study. Breast Cancer Res Treat. 2014
Apr;144(2):379-89. doi: 10.1007/s10549-014-2864-3. Epub 2014 Feb 12. PubMed PMID:
24519389.
17: Badani KK, Thompson DJ, Brown G, Holmes D, Kella N, Albala D, Singh A, Buerki
C, Davicioni E, Hornberger J. Effect of a genomic classifier test on clinical
practice decisions for patients with high-risk prostate cancer after surgery. BJU
Int. 2015 Mar;115(3):419-29. doi: 10.1111/bju.12789. Epub 2014 Aug 11. PubMed
PMID: 24784420; PubMed Central PMCID: PMC4371645.
18: Bancroft EK, Castro E, Ardern-Jones A, Moynihan C, Page E, Taylor N, Eeles
RA, Rowley E, Cox K. "It's all very well reading the letters in the genome, but
it's a long way to being able to write": Men's interpretations of undergoing
genetic profiling to determine future risk of prostate cancer. Fam Cancer. 2014
Dec;13(4):625-35. doi: 10.1007/s10689-014-9734-3. PubMed PMID: 24980079.
19: Bar J, Cyjon A, Flex D, Sorotsky H, Biran H, Dudnik J, Peylan-Ramu N, Peled
N, Nechushtan H, Gips M, Katsnelson R, Rosenberg SK, Merimsky O, Onn A, Gottfried
M. EGFR mutation testing practice in advanced non-small cell lung cancer. Lung.
2014 Oct;192(5):759-63. doi: 10.1007/s00408-014-9604-7. Epub 2014 Jun 26. PubMed
PMID: 24964874.
20: Batte BA, Bruegl AS, Daniels MS, Ring KL, Dempsey KM, Djordjevic B, Luthra R,
Fellman BM, Lu KH, Broaddus RR. Consequences of universal MSI/IHC in screening
ENDOMETRIAL cancer patients for Lynch syndrome. Gynecol Oncol. 2014
Aug;134(2):319-25. doi: 10.1016/j.ygyno.2014.06.009. Epub 2014 Jun 14. PubMed
PMID: 24933100; PubMed Central PMCID: PMC4125501.
21: Beadles CA, Ryanne Wu R, Himmel T, Buchanan AH, Powell KP, Hauser E, Henrich
VC, Ginsburg GS, Orlando LA. Providing patient education: impact on quantity and
quality of family health history collection. Fam Cancer. 2014 Jun;13(2):325-32.
doi: 10.1007/s10689-014-9701-z. PubMed PMID: 24515581.
22: Beamon CJ, Hardisty EE, Harris SC, Vora NL. A single center's experience with
noninvasive prenatal testing. Genet Med. 2014 Sep;16(9):681-7. doi:
10.1038/gim.2014.20. Epub 2014 Mar 27. PubMed PMID: 24675675.
23: Beitsch PD, Whitworth PW. Can breast surgeons provide breast cancer genetic
testing? An American Society of Breast Surgeons survey. Ann Surg Oncol. 2014
Dec;21(13):4104-8. doi: 10.1245/s10434-014-3711-9. Epub 2014 Apr 23. PubMed PMID:
24756810.
24: Bell DA, Kirke AB, Barbour R, Southwell L, Pang J, Burrows S, Watts GF. Can
patients be accurately assessed for familial hypercholesterolaemia in primary
care? Heart Lung Circ. 2014 Dec;23(12):1153-7. doi: 10.1016/j.hlc.2014.06.015.
Epub 2014 Jul 5. PubMed PMID: 25065543.
25: Bell GC, Crews KR, Wilkinson MR, Haidar CE, Hicks JK, Baker DK, Kornegay NM,
Yang W, Cross SJ, Howard SC, Freimuth RR, Evans WE, Broeckel U, Relling MV,
Hoffman JM. Development and use of active clinical decision support for
preemptive pharmacogenomics. J Am Med Inform Assoc. 2014 Feb;21(e1):e93-9. doi:
10.1136/amiajnl-2013-001993. Epub 2013 Aug 26. PubMed PMID: 23978487; PubMed
Central PMCID: PMC3957400.
26: Benn P, Chapman AR, Erickson K, Defrancesco MS, Wilkins-Haug L, Egan JF,
Schulkin J. Obstetricians and gynecologists' practice and opinions of expanded
carrier testing and noninvasive prenatal testing. Prenat Diagn. 2014
Feb;34(2):145-52. doi: 10.1002/pd.4272. Epub 2013 Dec 16. PubMed PMID: 24222397.
27: Bensend TA, Veach PM, Niendorf KB. What's the harm? Genetic counselor
perceptions of adverse effects of genetics service provision by non-genetics
professionals. J Genet Couns. 2014 Feb;23(1):48-63. doi:
10.1007/s10897-013-9605-3. Epub 2013 Jun 12. PubMed PMID: 23754506.
28: Bernardes CM, Valery PC, Garvey G. Exploring the cancer risk perception and
interest in genetic services among Indigenous people in Queensland, Australia.
Aust N Z J Public Health. 2014 Aug;38(4):344-8. doi: 10.1111/1753-6405.12256.
Erratum in: Aust N Z J Public Health. 2015 Jun;39(3):292. PubMed PMID: 25091074.
29: Bernhardt BA, Kellom K, Barbarese A, Faucett WA, Wapner RJ. An exploration of
genetic counselors' needs and experiences with prenatal chromosomal microarray
testing. J Genet Couns. 2014 Dec;23(6):938-47. doi: 10.1007/s10897-014-9702-y.
Epub 2014 Feb 27. PubMed PMID: 24569858; PubMed Central PMCID: PMC4147030.
30: Blanchette PS, Spreafico A, Miller FA, Chan K, Bytautas J, Kang S, Bedard PL,
Eisen A, Potanina L, Holland J, Kamel-Reid S, McPherson JD, Razak AR, Siu LL.
Genomic testing in cancer: patient knowledge, attitudes, and expectations.
Cancer. 2014 Oct 1;120(19):3066-73. doi: 10.1002/cncr.28807. Epub 2014 Jun 24.
PubMed PMID: 24962202.
31: Bloss CS, Schork NJ, Topol EJ. Direct-to-consumer pharmacogenomic testing is
associated with increased physician utilisation. J Med Genet. 2014
Feb;51(2):83-9. doi: 10.1136/jmedgenet-2013-101909. Epub 2013 Dec 16. PubMed
PMID: 24343916.
32: Bombard Y, Miller FA, Hayeems RZ, Barg C, Cressman C, Carroll JC, Wilson BJ,
Little J, Avard D, Painter-Main M, Allanson J, Giguere Y, Chakraborty P. Public
views on participating in newborn screening using genome sequencing. Eur J Hum
Genet. 2014 Nov;22(11):1248-54. doi: 10.1038/ejhg.2014.22. Epub 2014 Feb 19.
PubMed PMID: 24549052; PubMed Central PMCID: PMC4200434.
33: Bombard Y, Rozmovits L, Trudeau M, Leighl NB, Deal K, Marshall DA. Access to
personalized medicine: factors influencing the use and value of gene expression
profiling in breast cancer treatment. Curr Oncol. 2014 Jun;21(3):e426-33. doi:
10.3747/co.21.1782. PubMed PMID: 24940102; PubMed Central PMCID: PMC4059806.
34: Borzekowski DL, Guan Y, Smith KC, Erby LH, Roter DL. The Angelina effect:
immediate reach, grasp, and impact of going public. Genet Med. 2014
Jul;16(7):516-21. doi: 10.1038/gim.2013.181. Epub 2013 Dec 19. PubMed PMID:
24357847.
35: Brannon Traxler L, Martin ML, Kerber AS, Bellcross CA, Crane BE, Green V,
Matthews R, Paris NM, Gabram SG. Implementing a screening tool for identifying
patients at risk for hereditary breast and ovarian cancer: a statewide
initiative. Ann Surg Oncol. 2014 Oct;21(10):3342-7. doi:
10.1245/s10434-014-3921-1. Epub 2014 Jul 22. PubMed PMID: 25047474.
36: Brewer NT, Defrank JT, Chiu WK, Ibrahim JG, Walko CM, Rubin P, Olajide OA,
Moore SG, Raab RE, Carrizosa DR, Corso SW, Schwartz G, Peppercorn JM, McLeod HL,
Carey LA, Irvin WJ Jr. Patients' understanding of how genotype variation affects
benefits of tamoxifen therapy for breast cancer. Public Health Genomics.
2014;17(1):43-7. doi: 10.1159/000356565. Epub 2014 Jan 22. PubMed PMID: 24457521;
PubMed Central PMCID: PMC4058990.
37: Brierley KL, Bonadies DC, Moyer A, Matloff ET. "Would you test your children
without their consent?" and other sticky dilemmas in the field of cancer genetic
testing. Fam Cancer. 2014 Sep;13(3):345-50. doi: 10.1007/s10689-014-9723-6.
PubMed PMID: 24804937.
38: Buchanan AH, Christianson CA, Himmel T, Powell KP, Agbaje A, Ginsburg GS,
Henrich VC, Orlando LA. Use of a patient-entered family health history tool with
decision support in primary care: impact of identification of increased risk
patients on genetic counseling attendance. J Genet Couns. 2015 Feb;24(1):179-88.
doi: 10.1007/s10897-014-9753-0. Epub 2014 Aug 15. PubMed PMID: 25120038.
39: Bui ET, Anderson NK, Kassem L, McMahon FJ. Do participants in genome
sequencing studies of psychiatric disorders wish to be informed of their results?
A survey study. PLoS One. 2014 Jul 1;9(7):e101111. doi:
10.1371/journal.pone.0101111. eCollection 2014. PubMed PMID: 24983240; PubMed
Central PMCID: PMC4077756.
40: Burstein MD, Robinson JO, Hilsenbeck SG, McGuire AL, Lau CC. Pediatric data
sharing in genomic research: attitudes and preferences of parents. Pediatrics.
2014 Apr;133(4):690-7. doi: 10.1542/peds.2013-1592. Epub 2014 Mar 10. PubMed
PMID: 24616359; PubMed Central PMCID: PMC3966500.
41: Buseh A, Kelber S, Millon-Underwood S, Stevens P, Townsend L. Knowledge,
group-based medical mistrust, future expectations, and perceived disadvantages of
medical genetic testing: perspectives of Black African immigrants/refugees.
Public Health Genomics. 2014;17(1):33-42. doi: 10.1159/000356013. Epub 2013 Dec
24. PubMed PMID: 24401187.
42: Butrick M, Kelly S, Peshkin BN, Luta G, Nusbaum R, Hooker GW, Graves K,
Feeley L, Isaacs C, Valdimarsdottir HB, Jandorf L, DeMarco T, Wood M, McKinnon W,
Garber J, McCormick SR, Schwartz MD. Disparities in uptake of BRCA1/2 genetic
testing in a randomized trial of telephone counseling. Genet Med. 2015
Jun;17(6):467-75. doi: 10.1038/gim.2014.125. Epub 2014 Sep 18. PubMed PMID:
25232856; PubMed Central PMCID: PMC4364924.
43: Cameron E, Rose S, Carey M. Assessment of family history of colorectal cancer
in primary care: perceptions of first degree relatives of people with colorectal
cancer. Patient Educ Couns. 2014 Mar;94(3):427-31. doi:
10.1016/j.pec.2013.11.014. Epub 2013 Dec 14. PubMed PMID: 24380670.
44: Cartwright T, Chao C, Lee M, Lopatin M, Bentley T, Broder M, Chang E. Effect
of the 12-gene colon cancer assay results on adjuvant treatment recommendations
in patients with stage II colon cancer. Curr Med Res Opin. 2014 Feb;30(2):321-8.
doi: 10.1185/03007995.2013.855183. Epub 2013 Nov 7. PubMed PMID: 24127781.
45: Caselli RJ, Langbaum J, Marchant GE, Lindor RA, Hunt KS, Henslin BR, Dueck
AC, Robert JS. Public perceptions of presymptomatic testing for Alzheimer
disease. Mayo Clin Proc. 2014 Oct;89(10):1389-96. doi:
10.1016/j.mayocp.2014.05.016. Epub 2014 Aug 26. PubMed PMID: 25171823; PubMed
Central PMCID: PMC4369785.
46: Chan SL, Low JJ, Chia KS, Wee HL. Attitudes on warfarin pharmacogenetic
testing in Chinese patients and public. Int J Technol Assess Health Care. 2014
Jan;30(1):113-20. doi: 10.1017/S026646231300069X. Epub 2014 Jan 27. PubMed PMID:
24468050.
47: Chan YM, Leung TY, Chan OK, Cheng YK, Sahota DS. Patient's choice between a
non-invasive prenatal test and invasive prenatal diagnosis based on test
accuracy. Fetal Diagn Ther. 2014;35(3):193-8. doi: 10.1159/000356075. Epub 2013
Nov 13. PubMed PMID: 24247224.
48: Christenhusz GM, Devriendt K, Peeters H, Van Esch H, Dierickx K. The
communication of secondary variants: interviews with parents whose children have
undergone array-CGH testing. Clin Genet. 2014 Sep;86(3):207-16. doi:
10.1111/cge.12354. Epub 2014 Mar 6. PubMed PMID: 24479378.
49: Christian S, Blumenschein P, Lilley M. An assessment of Canadian systems for
triaging referred out genetic testing. Clin Genet. 2015 Jul;88(1):90-4. doi:
10.1111/cge.12435. Epub 2014 Jul 26. PubMed PMID: 25065508.
50: Cichon M, Feldman GL. Opportunities to improve recruitment into medical
genetics residency programs: survey results of program directors and medical
genetics residents. Genet Med. 2014 May;16(5):413-8. doi: 10.1038/gim.2013.161.
Epub 2013 Oct 17. PubMed PMID: 24136619.
51: Comas C, Echevarria M, Rodríguez MA, Prats P, Rodríguez I, Serra B. Initial
experience with non-invasive prenatal testing of cell-free DNA for major
chromosomal anomalies in a clinical setting. J Matern Fetal Neonatal Med. 2015
Jul;28(10):1196-201. doi: 10.3109/14767058.2014.947579. Epub 2014 Aug 12. PubMed
PMID: 25048745.
52: Connor JA, Hinton RB, Miller EM, Sund KL, Ruschman JG, Ware SM. Genetic
testing practices in infants with congenital heart disease. Congenit Heart Dis.
2014 Mar-Apr;9(2):158-67. doi: 10.1111/chd.12112. Epub 2013 Jun 20. PubMed PMID:
23782710.
53: Cortesi L, Razzaboni E, Toss A, De Matteis E, Marchi I, Medici V, Tazzioli G,
Andreotti A, De Santis G, Pignatti M, Federico M. A rapid genetic counselling and
testing in newly diagnosed breast cancer is associated with high rate of
risk-reducing mastectomy in BRCA1/2-positive Italian women. Ann Oncol. 2014
Jan;25(1):57-63. doi: 10.1093/annonc/mdt422. Epub 2013 Nov 24. PubMed PMID:
24276029.
54: Costain G, Esplen MJ, Toner B, Scherer SW, Meschino WS, Hodgkinson KA,
Bassett AS. Evaluating genetic counseling for individuals with schizophrenia in
the molecular age. Schizophr Bull. 2014 Jan;40(1):78-87. doi:
10.1093/schbul/sbs138. Epub 2012 Dec 12. PubMed PMID: 23236078; PubMed Central
PMCID: PMC3885288.
55: Cousens NE, Gaff CL, Delatycki MB, Metcalfe SA. Prenatal β-thalassemia
carrier screening in Australia: healthcare professionals' perspectives of
clinical practice. Prenat Diagn. 2014 Mar;34(3):246-50. doi: 10.1002/pd.4297.
Epub 2014 Jan 19. PubMed PMID: 24338659.
56: Cragun D, Camperlengo L, Robinson E, Caldwell M, Kim J, Phelan C, Monteiro
AN, Vadaparampil ST, Sellers TA, Pal T. Differences in BRCA counseling and
testing practices based on ordering provider type. Genet Med. 2015
Jan;17(1):51-7. doi: 10.1038/gim.2014.75. Epub 2014 Jun 12. PubMed PMID:
24922460; PubMed Central PMCID: PMC4264999.
57: Cragun D, DeBate RD, Vadaparampil ST, Baldwin J, Hampel H, Pal T. Comparing
universal Lynch syndrome tumor-screening programs to evaluate associations
between implementation strategies and patient follow-through. Genet Med. 2014
Oct;16(10):773-82. doi: 10.1038/gim.2014.31. Epub 2014 Mar 20. PubMed PMID:
24651603; PubMed Central PMCID: PMC4169758.
58: Crawford JM, Bry L, Pfeifer J, Caughron SK, Black-Schaffer S, Kant JA,
Kaufman JH. The business of genomic testing: a survey of early adopters. Genet
Med. 2014 Dec;16(12):954-61. doi: 10.1038/gim.2014.60. Epub 2014 Jul 10. PubMed
PMID: 25010053; PubMed Central PMCID: PMC4262758.
59: Cuccaro ML, Czape K, Alessandri M, Lee J, Deppen AR, Bendik E, Dueker N,
Nations L, Pericak-Vance M, Hahn S. Genetic testing and corresponding services
among individuals with autism spectrum disorder (ASD). Am J Med Genet A. 2014
Oct;164A(10):2592-600. doi: 10.1002/ajmg.a.36698. Epub 2014 Aug 4. PubMed PMID:
25131847.
60: Cuevas-Cuerda D, Salas-Trejo D. Evaluation after five years of the cancer
genetic counselling programme of Valencian Community (Eastern Spain). Fam Cancer.
2014 Jun;13(2):301-9. doi: 10.1007/s10689-013-9693-0. PubMed PMID: 24242329.
61: Cuffe S, Hon H, Qiu X, Tobros K, Wong CK, De Souza B, McFarlane G, Masroor S,
Azad AK, Hasani E, Rozanec N, Leighl N, Alibhai S, Xu W, Issa AM, Liu G. Cancer
patients acceptance, understanding, and willingness-to-pay for pharmacogenomic
testing. Pharmacogenet Genomics. 2014 Jul;24(7):348-55. doi:
10.1097/FPC.0000000000000061. PubMed PMID: 24911662.
62: Cunningham F, Lewis S, Curnow L, Glazner J, Massie J. Respiratory physicians
and clinic coordinators' attitudes to population-based cystic fibrosis carrier
screening. J Cyst Fibros. 2014 Jan;13(1):99-105. doi: 10.1016/j.jcf.2013.06.009.
Epub 2013 Jul 25. PubMed PMID: 23891279.
63: Darst BF, Madlensky L, Schork NJ, Topol EJ, Bloss CS. Characteristics of
genomic test consumers who spontaneously share results with their health care
provider. Health Commun. 2014;29(1):105-8. doi: 10.1080/10410236.2012.717216.
Epub 2013 Feb 5. PubMed PMID: 23384116; PubMed Central PMCID: PMC3679226.
64: de Groot M, Wessel J. Genetic Testing and Type 2 Diabetes Risk Awareness.
Diabetes Educ. 2014 Mar 19;40(4):427-433. [Epub ahead of print] PubMed PMID:
24648440; PubMed Central PMCID: PMC4474775.
65: de Groot-van der Mooren MD, Gemke RJ, Cornel MC, Weijerman ME. Neonatal
diagnosis of Down syndrome in The Netherlands: suspicion and communication with
parents. J Intellect Disabil Res. 2014 Oct;58(10):953-61. doi: 10.1111/jir.12125.
Epub 2014 Mar 14. PubMed PMID: 24628769.
66: Dekker N, Hermens RP, de Wilt JH, van Zelst-Stams WA, Hoogerbrugge N; RISCO
study group. Improving recognition and referral of patients with an increased
familial risk of colorectal cancer: results from a randomized controlled trial.
Colorectal Dis. 2015 Jun;17(6):499-510. doi: 10.1111/codi.12880. PubMed PMID:
25524559.
67: Dhiman P, Kai J, Horsfall L, Walters K, Qureshi N. Availability and quality
of coronary heart disease family history in primary care medical records:
implications for cardiovascular risk assessment. PLoS One. 2014 Jan
9;9(1):e81998. doi: 10.1371/journal.pone.0081998. eCollection 2014. PubMed PMID:
24416135; PubMed Central PMCID: PMC3886986.
68: Dias MM, Ward HM, Sorich MJ, McKinnon RA. Exploration of the perceptions,
barriers and drivers of pharmacogenomics practice among hospital pharmacists in
Adelaide, South Australia. Pharmacogenomics J. 2014 Jun;14(3):235-40. doi:
10.1038/tpj.2013.31. Epub 2013 Sep 10. PubMed PMID: 24018620.
69: Dilzell K, Kingham K, Ormond K, Ladabaum U. Evaluating the utilization of
educational materials in communicating about Lynch syndrome to at-risk relatives.
Fam Cancer. 2014 Sep;13(3):381-9. doi: 10.1007/s10689-014-9720-9. PubMed PMID:
24770865.
70: Dodson C. Knowledge and attitudes of oncology nurses regarding
pharmacogenomic testing. Clin J Oncol Nurs. 2014 Aug;18(4):E64-70. doi:
10.1188/14.CJON.E64-E70. PubMed PMID: 25095306.
71: Doyle N, Cirino A, Trivedi A, Flynn M. Exploring barriers to payer
utilization of genetic counselors. J Genet Couns. 2015 Feb;24(1):122-33. doi:
10.1007/s10897-014-9745-0. Epub 2014 Aug 20. PubMed PMID: 25138080.
72: Edelman EA, Lin BK, Doksum T, Drohan B, Edelson V, Dolan SM, Hughes KS,
O'Leary J, Galvin SL, Degroat N, Pardanani S, Feero WG, Adams C, Jones R, Scott
J. Implementation of an electronic genomic and family health history tool in
primary prenatal care. Am J Med Genet C Semin Med Genet. 2014 Mar;166C(1):34-44.
doi: 10.1002/ajmg.c.31389. Epub 2014 Mar 10. PubMed PMID: 24616345.
73: Edelman EA, Lin BK, Doksum T, Drohan B, Edelson V, Dolan SM, Hughes K,
O'Leary J, Vasquez L, Copeland S, Galvin SL, DeGroat N, Pardanani S, Gregory
Feero W, Adams C, Jones R, Scott J. Evaluation of a novel electronic genetic
screening and clinical decision support tool in prenatal clinical settings.
Matern Child Health J. 2014 Jul;18(5):1233-45. doi: 10.1007/s10995-013-1358-y.
PubMed PMID: 24101435.
74: Eichmeyer JN, Burnham C, Sproat P, Tivis R, Beck TM. The value of a genetic
counselor: improving identification of cancer genetic counseling patients with
chart review. J Genet Couns. 2014 Jun;23(3):323-9. doi:
10.1007/s10897-013-9664-5. Epub 2013 Oct 25. PubMed PMID: 24155015.
75: Elliott AM, Chodirker BN, Bocangel P, Mhanni AA. Evaluation of a clinical
genetics service--a quality initiative. J Genet Couns. 2014 Oct;23(5):881-9. doi:
10.1007/s10897-014-9713-8. Epub 2014 Mar 21. PubMed PMID: 24647747.